Silo Pharma (SILO) Other Non Operating Income (2020 - 2026)

Silo Pharma has reported Other Non Operating Income for 5 years, with the latest figure at -$2674.0 in Q1 2026.

• Quarterly Other Non Operating Income changed N/A year-over-year to -$2674.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8221.0 (changed N/A YoY) and the FY2024 annual result came in at -$14242.0, changed N/A from the prior year.
• Other Non Operating Income fell to -$2674.0 in Q1 2026 per SILO's latest filing, from -$2618.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $84.0 in Q1 2022 and troughed at -$8695.0 in Q1 2024.
• A 3-year average of -$2852.5 and a median of -$2646.0 in 2024 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 99.87% in 2022, down 101.48% in 2022.
• Over 3 years, Other Non Operating Income stood at -$283.0 in 2022, then slumped by 825.09% to -$2618.0 in 2024, then dropped by 2.14% to -$2674.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$2674.0, -$2618.0, and -$2929.0 for Q1 2026, Q3 2024, and Q2 2024 respectively.